For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Theriva Biologics Inc (AMEX: TOVX) was $0.22 for the day, up 0.79% from the previous closing price of $0.21. In other words, the price has increased by $0.79 from its previous closing price. On the day, 1.81 million shares were traded. TOVX stock price reached its highest trading level at $0.218 during the session, while it also had its lowest trading level at $0.2053.
Ratios:
Our analysis of TOVX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.90 and its Current Ratio is at 0.90. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.31.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TOVX now has a Market Capitalization of 7287763 and an Enterprise Value of 2521763.
Stock Price History:
The Beta on a monthly basis for TOVX is 0.45, which has changed by -0.83076924 over the last 52 weeks, in comparison to a change of 0.1028198 over the same period for the S&P500. Over the past 52 weeks, TOVX has reached a high of $2.08, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is -40.71%, while the 200-Day Moving Average is calculated to be -69.18%.
Shares Statistics:
TOVX traded an average of 14.41M shares per day over the past three months and 2301900 shares per day over the past ten days. A total of 33.74M shares are outstanding, with a floating share count of 32.97M. Insiders hold about 2.28% of the company’s shares, while institutions hold 1.30% stake in the company. Shares short for TOVX as of 1761868800 were 1985894 with a Short Ratio of 0.14, compared to 1759190400 on 239896. Therefore, it implies a Short% of Shares Outstanding of 1985894 and a Short% of Float of 5.89.
Earnings Estimates
. The current assessment of Theriva Biologics Inc (TOVX) involves the perspectives of 1 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.21 and low estimates of -$0.21.
Analysts are recommending an EPS of between -$2.15 and -$2.15 for the fiscal current year, implying an average EPS of -$2.15. EPS for the following year is -$0.75, with 1.0 analysts recommending between -$0.75 and -$0.75.
